Countercurrent dialysis is an alternative to tangential flow filtration (TFF) and single-pass TFF (SPTFF) for product concentration and buffer exchange. It uses ultrafiltration membranes familiar to our industry but separates small solutes via diffusion rather than convection. Recent literature has shown its ability to exchange solutes to ≥ 99.9% and concentrate mAbs to > 250 g/L and > 50 cP [1,2]. The single-pass nature of dialysis makes it suitable for batch, connected, or continuous processing. Compared to TFF, it is simpler to operate, uses less buffer to achieve the same levels of solute exchange, and enables intensified processing.
Nick Marchand
Senior Manager, R&D, Cytiva
Nick Marchand is a manager within Cytiva's R&D department focused on bioprocess testing of new filtration technology. He holds a B.S. and Ph.D. from Rensselaer Polytechnic Institute.